Rating History for NovaBay Pharmaceuticals (NBY) by Ladenburg Thalmann

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/26/2021 Jeffrey Cohen Maintain Buy
(N/A)
1.90
(1.75)
 
 
  Details